Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.205 USD | +2.08% | +5.48% | -25.92% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.92% | 409M | |
+42.82% | 739B | |
+32.34% | 598B | |
-5.75% | 353B | |
+17.78% | 318B | |
+3.51% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+7.04% | 164B |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.
- Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise